However, some CRGs with CNV loss, such as IDH2, MTHFD1L, and ABCE1, showed upregulated mRNA expression, while other CRGs with CNV gain, such as TPK1, showed downregulated mRNA expression between tumor and normal samples. The gene discussed is TPK1; the disease is neoplasm.